Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Bausch + Lomb (BLCO) to $16 from $17 and keeps an In Line rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb price target lowered to C$19 from C$21 at Citi
- Bausch + Lomb: Solid Q1 Beat and Pharma Momentum Offset by Spin-Off Uncertainty, Supporting Hold Rating
- Bausch + Lomb reports Q1 adjusted EPS 5c, consensus 5c
- Bausch + Lomb raises FY26 revenue view to $5.420B-$5.530B from $5.375B-$5.475B
- Bausch + Lomb announces narrative review on certain B vitamins